The Levothyroxine Sodium Tablets, cataloged under National Stock Number 6505-00-990-2021, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Boots Pharmaceuticals Inc. Government technical data includes 4 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 7 commercial cross-references from 2 manufacturers, enabling identification through both NSN and commercial part number lookups. 12 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Cancelled.
| Parameter | Value |
|---|---|
| NSN | 6505-00-990-2021 |
| Primary Part Number | SYNTHROID TABLETS |
| Item Name | Levothyroxine Sodium Tablets |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Boots Pharmaceuticals Inc |
| Status | CANCELLED |
| Active Medicament Medicinal Strength | 0.025 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Acquisition Status | CANCELLED |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| SYNTHROID TABLETS | Boots Pharmaceuticals Inc (USA) |
| LEVOTHROID TABLETS | Armour Pharmaceutical Co Div of Rorer-Poulec Rorer Inc (USA) |
| SYNTHROID | Boots Pharmaceuticals Inc (USA) |
| NDC00048-1020-03 | Boots Pharmaceuticals Inc (USA) |
| LEVOTHROID | Armour Pharmaceutical Co Div of Rorer-Poulec Rorer Inc (USA) |
| NDC00053-2540-06 | Armour Pharmaceutical Co Div of Rorer-Poulec Rorer Inc (USA) |
| 3P1023 | Boots Pharmaceuticals Inc (USA) |
NSN 6505-00-990-2021 is a Levothyroxine Sodium Tablets, manufactured by Boots Pharmaceuticals Inc, classified under FSC 6505 (No Item Name Available). Status: cancelled.
NSN 6505-00-990-2021 has 7 cross-referenced part numbers: SYNTHROID TABLETS (Boots Pharmaceuticals Inc), LEVOTHROID TABLETS (Armour Pharmaceutical Co Div of Rorer-Poulec Rorer Inc), SYNTHROID (Boots Pharmaceuticals Inc), NDC00048-1020-03 (Boots Pharmaceuticals Inc), LEVOTHROID (Armour Pharmaceutical Co Div of Rorer-Poulec Rorer Inc) and 2 more.
There are 12 known substitutes for 6505-00-990-2021: 6505-00-915-1630, 6505-01-042-9260, 6505-01-094-1636 and 9 more. Verify interchangeability with system specifications before substitution.
Key specifications for SYNTHROID TABLETS: Active Medicament Medicinal Strength: 0.025 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Primary Container Content Quantity: 100.000 TABLETS. 4 total characteristics are documented in the Federal Logistics Information System.
NSN 6505-00-990-2021 is currently cancelled. Check with the Defense Logistics Agency for current availability and authorized substitutes.